Annovis Bio to Present Twice at AD/PD 2026 International Conference

Reuters03-03

<a href="https://laohu8.com/S/ANVS">Annovis Bio</a> to Present Twice at AD/PD 2026 International Conference

Annovis Bio Inc. will attend the AD/PD 2026 International Conference, held March 17-21, 2026, in Copenhagen, Denmark, where it plans two presentations highlighting clinical data on buntanetap in Parkinson’s disease and an update on its ongoing pivotal Phase 3 trial in early Alzheimer’s disease. Event information: https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy53jgn4QMsKnzsPAI89qw3ZFpMHX04lZDGq3GkVgiFFMQ1UAEsFRXyv-jgur7HiDx_w== and https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy5zhVZnf4pFoT3IJsEnZel063WAfaoNsVEolvwt7u4GBAODkMSl62qi9a4ABld2cn1g==; conference website: https://www.globenewswire.com/Tracker?data=-kK3YlB4qDXSXNkBrR69pm2zprABSXYx1ZtDyNsL6yKVEX7DHzPc3hjjorY89-0KrW5OcZNsmC8RuBgimQS6Zw==.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603030800PRIMZONEFULLFEED9664451) on March 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616400553?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616400553","market":"fut","top_or_hot":-1,"title":"Annovis Bio to Present Twice at AD/PD 2026 International Conference","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ANVS\">Annovis Bio</a> to Present Twice at AD/PD 2026 International Conference\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Annovis Bio Inc. will attend the AD/PD 2026 International Conference, held March 17-21, 2026, in Copenhagen, Denmark, where it plans two presentations highlighting clinical data on buntanetap in Parkinson’s disease and an update on its ongoing pivotal Phase 3 trial in early Alzheimer’s disease. Event information: https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy53jgn4QMsKnzsPAI89qw3ZFpMHX04lZDGq3GkVgiFFMQ1UAEsFRXyv-jgur7HiDx_w== and https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy5zhVZnf4pFoT3IJsEnZel063WAfaoNsVEolvwt7u4GBAODkMSl62qi9a4ABld2cn1g==; conference website: https://www.globenewswire.com/Tracker?data=-kK3YlB4qDXSXNkBrR69pm2zprABSXYx1ZtDyNsL6yKVEX7DHzPc3hjjorY89-0KrW5OcZNsmC8RuBgimQS6Zw==.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603030800PRIMZONEFULLFEED9664451) on March 03, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annovis Bio to Present Twice at AD/PD 2026 International Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnovis Bio to Present Twice at AD/PD 2026 International Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-03 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ANVS\">Annovis Bio</a> to Present Twice at AD/PD 2026 International Conference\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Annovis Bio Inc. will attend the AD/PD 2026 International Conference, held March 17-21, 2026, in Copenhagen, Denmark, where it plans two presentations highlighting clinical data on buntanetap in Parkinson’s disease and an update on its ongoing pivotal Phase 3 trial in early Alzheimer’s disease. Event information: https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy53jgn4QMsKnzsPAI89qw3ZFpMHX04lZDGq3GkVgiFFMQ1UAEsFRXyv-jgur7HiDx_w== and https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy5zhVZnf4pFoT3IJsEnZel063WAfaoNsVEolvwt7u4GBAODkMSl62qi9a4ABld2cn1g==; conference website: https://www.globenewswire.com/Tracker?data=-kK3YlB4qDXSXNkBrR69pm2zprABSXYx1ZtDyNsL6yKVEX7DHzPc3hjjorY89-0KrW5OcZNsmC8RuBgimQS6Zw==.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603030800PRIMZONEFULLFEED9664451) on March 03, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999014039.USD","symbol_name":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL1HS2WS:1","article_id":"2616400553","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616400553","pubTimestamp":1772542961,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Annovis Bio to Present Twice at AD/PD 2026 International Conference               Annovis Bio Inc. will attend the AD/PD 2026 International Conference, held March 17-21, 2026, in Copenhagen, Denmark, ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","NDAQ":"纳斯达克OMX交易所","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","ANVS":"Annovis Bio, Inc.","BK4588":"碎股","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4112":"金融交易所和数据","BK4139":"生物科技","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD"},"translate_title":"Annovis Bio将两次出席AD/PD 2026国际会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"ANVS":0.9},"content_text":"Annovis Bio to Present Twice at AD/PD 2026 International Conference\n    \n\n        Annovis Bio Inc. will attend the AD/PD 2026 International Conference, held March 17-21, 2026, in Copenhagen, Denmark, where it plans two presentations highlighting clinical data on buntanetap in Parkinson’s disease and an update on its ongoing pivotal Phase 3 trial in early Alzheimer’s disease. Event information: https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy53jgn4QMsKnzsPAI89qw3ZFpMHX04lZDGq3GkVgiFFMQ1UAEsFRXyv-jgur7HiDx_w== and https://www.globenewswire.com/Tracker?data=EvJgQrvl4J_561c9XoJy5zhVZnf4pFoT3IJsEnZel063WAfaoNsVEolvwt7u4GBAODkMSl62qi9a4ABld2cn1g==; conference website: https://www.globenewswire.com/Tracker?data=-kK3YlB4qDXSXNkBrR69pm2zprABSXYx1ZtDyNsL6yKVEX7DHzPc3hjjorY89-0KrW5OcZNsmC8RuBgimQS6Zw==.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603030800PRIMZONEFULLFEED9664451) on March 03, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616400553","isCrawlerRequest":true}